Overview

Investors

Lucite International, Owner of the world-renowned Lucite and Perspex brands and the global leader in the innovation, design and manufacture of acrylic based products has a turnover of over $1 billion. As the world leader in the methacrylates market with a long term market share of 25%, it employs over 2000 people at 15 manufacturing sites and 35 sales offices globally.

Key shareholders include Charterhouse Development Capital at 78% and employees at 9%.

Charterhouse Development Capital (CDC)

Charterhouse Development Capital is the UK’s longest established private equity firm and has been an active investor in Continental Europe for approximately 30 years.

• Since 1982, Charterhouse Development Capital has raised seven funds totalling approximately €3.5 billion for investment in the UK and Europe. During this period, Charterhouse has invested in over 110 businesses in seven European countries with a total value of over €18 billion.
• The CDC team is lead by Gordon Bonnyman and the longest serving director, Geoff Arbuthnott, is currently the Chairman of Lucite International.
• CDC formed their seventh fund which has just over €2.7billion of commitments. Its first investment is the UK bookmaker, Corals which it bought in October 2002.
• CDC’s investment philosophy is to support their investments with funds to expand. Examples of this include Tussauds which has bought a German theme park and opened wax works in New York and Las Vegas, TDF (which it bought in 2002 for just under €2billion) buying overseas “towers” businesses and rolling out 3G in France, Corals buying smaller bookmakers in the UK and finally and most importantly, CDC supporting a new plant in China and the continued development and roll out of Lucite International's new MMA technology – Alpha.